SCO-116

N/A

Report date: 2023/10/26 11:33:23
NME

Base Information

Drug NameSCO-116
Drug Alias NameSCO-116KTX-101KTX-1161
ClassificationSmall molecules
Mechanisms of ActionNuclear factor erythroid 2-related factor 2 stimulants
TargetsNuclear factor erythroid 2-related factor 2
Therapy Area/IndicationsRenal InsufficiencyDiabetic NephropathiesEye Diseases +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesScohia Pharma Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsRenal InsufficiencyDiabetic NephropathiesEye Diseases +[5
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A